Evonik
Finally this week our attention moves to Evonik, the speciality chemical company who has appointed Christian Kullmann (left) as Executive Vice President and head of the company's new General Secretariat.
His previous role of head of Communications/Board Office will be taken by Stefan Haver (right).
And Evonik is one of the companies giving a featured presentation a special live webinar, the “Bioavailability challenge 2013” a free to ‘attend’ online webinar series on March 20 focused on the difficulties developers face in ensuring their drug candidates are bioavailable.
Our editorial programme will feature contributions from Big Pharma firms Bristol-Myers Squibb (B-MS) and Hoffman La Roche and analysts group Frost & Sullivan will share its overview of the bioavailability services market.
The event will also feature other presentations from scientists from Agere Pharmaceutical, Ashland, BASF, Bend, Dow, Capsugel, and Catalent.
Click here to sign up for the show. See you on March 20.